anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.05.24 | Roche Hold | Deutsche Bank AG | |
| 16.05.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.05.24 | Roche Hold | Jefferies & Company Inc. | |
| 14.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Novartis Buy | UBS AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.24 | Roche Neutral | UBS AG | |
| 25.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Roche Kaufen | DZ BANK | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.24 | Roche Sell | Deutsche Bank AG | |
| 22.03.24 | Novartis Buy | Deutsche Bank AG |